Years after Sanofi's Dengvaxia fiasco, Takeda lands first OK for its own dengue vaccine

Takeda has scored a landmark approval for its dengue vaccine, the first step in helping tackle what the WHO has defined as a top 10 health problem and cracking open a potential blockbuster market.